Physician

Chetan Bharat Patel, M.D.

According to 2025 Medicare claims, Chetan Patel, M.D. (NPI: 1730256835) practices advanced heart failure and transplant cardiology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27705-4699. Patel is affiliated with the Duke Connected Care, LLC (ACO ID: A2419) and Triad HealthCare Network, LLC. (ACO ID: D0209), participating under both the MSSP and REACH models.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 277 traditional Medicare patients, billed 1,038 HCPCS/CPT codes, and received $63,791 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 2,613 prescription claims across 382 beneficiaries totaling $447,514 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 529 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $125,499 to $63,791. Similarly, Part D prescription costs have fallen sharply in recent years, from $890,957 to $447,514. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $28,010 to $11,620.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	439	2,408	$125,499
2016	449	2,200	$105,247
2017	471	1,933	$98,106
2018	475	1,600	$89,915
2019	331	1,102	$63,654
2020	307	1,079	$67,257
2021	345	1,109	$75,401
2022	342	939	$71,580
2023	289	920	$70,178
2024	277	1,038	$63,791

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	406	7,906	$890,957
2016	406	8,763	$787,745
2017	446	9,804	$1,014,325
2018	449	10,206	$1,017,424
2019	463	10,030	$952,972
2020	486	10,038	$1,111,744
2021	485	7,377	$814,577
2022	363	2,152	$370,838
2023	337	2,369	$430,370
2024	382	2,613	$447,514

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	469	3,181	$361,216
2016	537	4,217	$568,287
2017	545	4,324	$305,691
2018	596	4,760	$346,983
2019	554	4,597	$257,215
2020	628	4,810	$281,826
2021	492	3,198	$185,640
2022	107	452	$27,794
2023	38	347	$18,376
2024	66	529	$40,274

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	61	259	$82
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	184	241	$65
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	34	88	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	25	26	$39
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	184	240	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	152	7,048	$156,024
Eliquis	Apixaban	105	5,049	$94,663
Jardiance	Empagliflozin	99	4,785	$93,502
Farxiga	Dapagliflozin Propanediol	19	1,080	$18,925
Tacrolimus	Tacrolimus	108	5,009	$9,877

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	12	$15,650
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	43	$10,292
J7507	Tacrolimus, immediate release, oral, 1 mg	N	18	86	$3,637
J2260	Injection, milrinone lactate, 5 mg	N	N/R	41	$1,840
J7515	Cyclosporine, oral, 25 mg	N	N/R	20	$1,621

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Chetan Bharat Patel, M.D.?

Tedicare shows public-source Medicare data for Chetan Bharat Patel, M.D. (NPI 1730256835), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chetan Bharat Patel, M.D. have ACO affiliation data?

Chetan Bharat Patel, M.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419) and Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Chetan Bharat Patel, M.D.?

Chetan Bharat Patel, M.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Chetan Bharat Patel, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.